(Q51500891)

6 April 2018

title

Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. (English)

1 reference

6 April 2018

5

David R Jacobs

1 reference

6 April 2018

author name string

Michael W Steffes

1

1 reference

6 April 2018

Myron D Gross

2

1 reference

6 April 2018

Duk-Hee Lee

3

1 reference

6 April 2018

Pamela J Schreiner

4

1 reference

6 April 2018

publication date

1 February 2006

1 reference

6 April 2018

published in

Obesity

1 reference

6 April 2018

volume

14

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

319-326

1 reference

6 April 2018

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Adiponectin and development of type 2 diabetes in the Pima Indian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Plasma adiponectin levels and risk of myocardial infarction in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Serum adiponectin in young adults--interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Regulation of reverse cholesterol transport and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

Genetics of HDL regulation in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.41

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.41

1 reference

6 April 2018

PubMed ID

16571859

1 reference

6 April 2018